Featured Post

Latest Gold News

Gold may do even better in second half   Japan the new frontier for gold mining? Russia, China preparing to conduct energy transaction...

Monday, January 9, 2012

Progress (PRGS) (SGEN) (AMLN) (RCII) (RMBS) (TTWO) Ratings, Price Targets

Progress Software (NASDAQ: PRGS), Seattle Genetics, Inc. (NASDAQ: SGEN), Amylin Pharma (NASDAQ: AMLN), Rent-A-Center, Inc. (NASDAQ: RCII), Rambus Inc. (NASDAQ: RMBS) and Take-Two (NASDAQ: TTWO) ratings and price targets.

Progress Software (PRGS) had its “Buy” rating reiterated by Needham & Company.

Seattle Genetics, Inc. (SGEN) had its “Sell” rating reiterated by Canaccord Genuity.

Amylin Pharma (AMLN) is now covered by Rodman & Renshaw. They placed an “Underperform” rating and a price target of $8.00 on the company.

Rent-A-Center, Inc. (NASDAQ: RCII) had its “Neutral” rating reiterated by Zacks Investment Research. They have a price target of $39.00 on the company.

Rambus Inc. (RMBS) had its “Neutral” rating reiterated by JPMorgan Chase & Co. (NYSE:JPM). They have a price target of $11.50 on the company.

Take-Two (TTWO) was upgraded by MKM Partners from a “Neutral” rating to a “Buy” rating. They have a price target of $20.00 on the company, up from $16.00.

No comments: